Free Trial

GoHealth, Inc. (NASDAQ:GOCO) Short Interest Update

GoHealth logo with Finance background

Key Points

  • GoHealth, Inc. (NASDAQ:GOCO) experienced a substantial increase in short interest of 65.9% in September, with a total of 199,900 shares sold short by the end of the month.
  • The company's stock has been downgraded by multiple analysts, including a recent cut in price target from $18.00 to $12.00 by Royal Bank Of Canada.
  • GoHealth reported an earnings loss of ($1.23) per share for the last quarter, outperforming analysts' expectations of a larger loss but falling short of revenue estimates with $94.05 million in revenue.
  • MarketBeat previews the top five stocks to own by November 1st.

GoHealth, Inc. (NASDAQ:GOCO - Get Free Report) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totaling 199,900 shares, an increase of 65.9% from the September 15th total of 120,500 shares. Based on an average daily volume of 44,300 shares, the short-interest ratio is presently 4.5 days. Currently, 1.8% of the company's shares are sold short. Currently, 1.8% of the company's shares are sold short. Based on an average daily volume of 44,300 shares, the short-interest ratio is presently 4.5 days.

Analysts Set New Price Targets

GOCO has been the topic of a number of research reports. Weiss Ratings restated a "sell (d-)" rating on shares of GoHealth in a research report on Tuesday, October 14th. Wall Street Zen downgraded shares of GoHealth from a "hold" rating to a "sell" rating in a research report on Friday, July 18th. Noble Financial reiterated an "outperform" rating on shares of GoHealth in a research report on Friday, August 8th. Finally, Royal Bank Of Canada cut their price target on shares of GoHealth from $18.00 to $12.00 and set a "sector perform" rating on the stock in a research report on Thursday, August 28th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, GoHealth has a consensus rating of "Hold" and an average price target of $12.00.

Get Our Latest Stock Report on GoHealth

GoHealth Stock Down 1.1%

GOCO traded down $0.05 during trading on Wednesday, reaching $4.46. The company had a trading volume of 23,351 shares, compared to its average volume of 56,122. The company has a debt-to-equity ratio of 2.64, a current ratio of 1.56 and a quick ratio of 1.56. GoHealth has a 12 month low of $4.30 and a 12 month high of $21.00. The company has a market cap of $127.60 million, a P/E ratio of -1.24 and a beta of 1.62. The business's fifty day moving average price is $4.89 and its 200 day moving average price is $6.36.

GoHealth (NASDAQ:GOCO - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported ($1.23) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.60) by $1.37. The company had revenue of $94.05 million for the quarter, compared to the consensus estimate of $119.76 million. GoHealth had a negative net margin of 3.21% and a negative return on equity of 8.74%. Equities analysts anticipate that GoHealth will post -5.5 EPS for the current year.

Hedge Funds Weigh In On GoHealth

A number of institutional investors have recently added to or reduced their stakes in the company. N.E.W. Advisory Services LLC bought a new stake in shares of GoHealth in the first quarter valued at about $45,000. American Century Companies Inc. bought a new stake in GoHealth during the second quarter worth about $63,000. Bank of America Corp DE lifted its position in GoHealth by 22.8% during the fourth quarter. Bank of America Corp DE now owns 7,831 shares of the company's stock worth $105,000 after purchasing an additional 1,452 shares during the period. Cubist Systematic Strategies LLC lifted its position in GoHealth by 297.3% during the first quarter. Cubist Systematic Strategies LLC now owns 10,915 shares of the company's stock worth $134,000 after purchasing an additional 8,168 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its position in GoHealth by 50.5% during the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 26,013 shares of the company's stock worth $144,000 after purchasing an additional 8,734 shares during the period. 24.21% of the stock is currently owned by institutional investors and hedge funds.

About GoHealth

(Get Free Report)

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in GoHealth Right Now?

Before you consider GoHealth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoHealth wasn't on the list.

While GoHealth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.